Retrospective Multi-cohort Study of Frontline Afatinib Followed by 2nd Line Therapy Including Osimertinib, Chemotherapy or Other Therapy
Clinical trial NCT04930133 · UNKNOWN
Trial details
- NCT number
- NCT04930133
- Sponsor
- Seoul St. Mary's Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-02-24
- Primary completion
- 2020-12-17
- Enrollment
- 737
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.